Callisto Pharmaceuticals
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
420 Lexington Ave Ste 1609, New York Cit...Phone Number
(212) 297-0170Website
www.callistopharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Callisto Pharmaceuticals
Callisto Pharmaceuticals, Inc. is a publicly traded biotechnology company focused on the clinical development of cancer treatments, specifically Annamycin for relapsed leukemia and Atiprimod for relapsed multiple myeloma. The company is engaged in various clinical trials and has drugs in preclinical development for melanoma and gastrointestinal inflammation. Callisto operates through its subsidiaries, Callisto Research Labs, LLC and Synergy Pharmaceuticals Inc., and holds exclusive licenses for its key drugs. Its intended clients include patients suffering from specific types of cancer and healthcare providers involved in oncology.Explore more
Callisto Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Callisto Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Callisto Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Callisto Pharmaceuticals had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Callisto Pharmaceuticals has new funding data
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Callisto Pharmaceuticals
Check if Callisto Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Callisto Pharmaceuticals recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Callisto Pharmaceuticals is spiking on competitors!
Product Launch: Get notified when Callisto Pharmaceuticals launches new products
Recommended Actions
Reach out to Masked Content who joined Callisto Pharmaceuticals as Masked Content
Find more new buyers
Compare Similar Companies to Callisto Pharmaceuticals
Compare insights from companies similar to Callisto Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
1-10
Private
-
2015
WM
William McCullochChief Medical Officer, Chair of The Clinical Advisory Board
Company Profile Activity
Activity Insights
Callisto Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Callisto Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Callisto Pharmaceuticals.
Callisto Pharmaceuticals Tech Stack
A closer look at the technologies used by Callisto Pharmaceuticals
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Callisto Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Callisto Pharmaceuticals, Inc. is a publicly traded biotechnology company focused on the clinical development of cancer treatments, specifically Annamycin for relapsed leukemia and Atiprimod for relapsed multiple myeloma. The company is engaged in various clinical trials and has drugs in preclinical development for melanoma and gastrointestinal inf... Read More
